4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
3.620
-0.090 (-2.43%)
At close: May 30, 2025, 4:00 PM
3.600
-0.020 (-0.55%)
After-hours: May 30, 2025, 5:32 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $167.70 million as of May 30, 2025. Its market cap has decreased by -87.32% in one year.
Market Cap
167.70M
Enterprise Value
-266.89M
1-Year Change
-87.32%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $167.70M, a decrease of -71.11%. That is a compound annual growth rate of -24.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 171.86M | -33.25% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |